Atherogenic index of plasma is positively associated with the risk of all-cause death in elderly women : A 10-year follow-up

. 2017 Nov ; 129 (21-22) : 793-798. [epub] 20170914

Jazyk angličtina Země Rakousko Médium print-electronic

Typ dokumentu časopisecké články, pozorovací studie

Perzistentní odkaz   https://www.medvik.cz/link/pmid28913629
Odkazy

PubMed 28913629
DOI 10.1007/s00508-017-1264-1
PII: 10.1007/s00508-017-1264-1
Knihovny.cz E-zdroje

BACKGROUND: The blood concentrations of total cholesterol and low-density lipoprotein (LDL) do not predict survival in patients older than 60 years. The atherogenic index of plasma (AIP) is a logarithm of the triacylglycerol to high-density lipoprotein (HDL) ratio and a surrogate for the concentration of small dense LDL. It might be a better reflection of the risk of all-cause death in elderly patients. METHODS: We conducted a prospective observational study of patients with arterial hypertension older than 60 years. The concentrations of total cholesterol, LDL, HDL and triacylglycerol were measured at the time of the recruitment and the patients were observed for 10 years. Cox regression analysis was performed to assess the effects of lipoproteins and AIP on survival. RESULTS: A total of 500 patients were recruited and 473 of them (226 men, 247 women) either died or successfully completed the 10-year follow-up and were included in the analysis. The AIP was positively associated, while HDL concentration was negatively associated with the risk of all-cause death adjusted for age, smoking habits, statin use, history of diabetes mellitus, myocardial infarction, stroke and peripheral artery occlusive disease (PAOD) in elderly women but not in men. The LDL, total cholesterol, triacylglycerol and non-HDL concentrations were not associated with the risk of death in both sexes. CONCLUSIONS: The AIP is positively associated with the risk of all-cause death in elderly women with arterial hypertension independent of age, smoking habits, statin therapy and comorbidities.

Zobrazit více v PubMed

Arch Intern Med. 2003 Jul 14;163(13):1549-54 PubMed

ScientificWorldJournal. 2012;2012:930139 PubMed

Prim Care Diabetes. 2015 Feb;9(1):60-7 PubMed

J Gerontol A Biol Sci Med Sci. 2010 May;65(5):559-64 PubMed

Am J Epidemiol. 2004 Jul 15;160(2):150-7 PubMed

Circulation. 1997 Jul 1;96(1):37-43 PubMed

Am Heart J. 2000 Sep;140(3):521-6 PubMed

Lipids Health Dis. 2011 Jan 25;10 :21 PubMed

Metabolism. 2004 Apr;53(4):476-82 PubMed

Circulation. 2009 Jan 27;119(3):e21-181 PubMed

Lancet. 2001 Dec 15;358(9298):2026-33 PubMed

Eur Heart J. 2014 Nov 7;35(42):2950-9 PubMed

Aging Dis. 2013 Mar 01;4(3):154-69 PubMed

Clin Biochem. 2001 Oct;34(7):583-8 PubMed

J Geriatr Cardiol. 2015 Jul;12(4):431-8 PubMed

Scand J Prim Health Care. 2013 Sep;31(3):172-80 PubMed

Circulation. 1998 May 12;97(18):1837-47 PubMed

Diabetes Care. 2003 Jan;26(1):16-23 PubMed

Ann Intern Med. 1961 Jul;55:33-50 PubMed

Metabolism. 2002 Sep;51(9):1081-7 PubMed

Am Heart J. 2006 Mar;151(3):556-63 PubMed

Circulation. 1997 Jan 7;95(1):69-75 PubMed

J Clin Lipidol. 2010 Mar-Apr;4(2):89-98 PubMed

BMJ Open. 2016 Jun 12;6(6):e010401 PubMed

Eur J Clin Invest. 2012 Jun;42(6):631-6 PubMed

Eur Heart J. 2015 Jan 1;36(1):31-8 PubMed

Clin Chem. 2011 Mar;57(3):490-501 PubMed

J Lipid Res. 2011 Mar;52(3):566-71 PubMed

J Am Geriatr Soc. 2005 Dec;53(12):2159-64 PubMed

Bosn J Basic Med Sci. 2011 Aug;11(3):169-73 PubMed

J Am Coll Cardiol. 2007 Feb 6;49(5):547-53 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...